Repositorio Dspace

Listar Enfermedades Desmielinizantes por autor "Willi, Roman"

Listar Enfermedades Desmielinizantes por autor "Willi, Roman"

Ordenar por:Orden:Resultados:

  • Kappos, Ludwig; Bar-Or, Amit; Cohen, Jeffrey A.; Comi, Giancarlo; Correale, Jorge; Coyle, Patricia K.; Cross, Anne H.; de Seze, Jerome; Montalban, Xavier; Selmaj, Krzysztof; Wiendl, Heinz; Leppert, David; Kerloeguen, Cecile; Willi, Roman; Häring, Dieter A.; Tomic, Davorka; Goodyear, Alexandra; Merschhemke, Martin; Hauser, Stephen L. (Lippincott Williams & Wilkins, 2019-04-16)
    Objective: To present the baseline characteristics of patients enrolled in the ASCLEPIOS I and II trials. Background: ASCLEPIOS I and II are two Phase 3 trials of identical design that are being conducted simultaneously ...
  • Hauser, Stephen L.; Bar-Or, Amit; Cohen, Jeffrey A.; Comi, Giancarlo; Correale, Jorge; Coyle, Patricia K.; Cross, Anne H.; de Seze, Jerome; Montalban, Xavier; Selmaj, Krzysztof; Wiendl, Heinz; Willi, Roman; Li, Bingbing; Häring, Dieter A.; Ramnathan, Krishnan; Merschhemke, Martin; Kappos, Ludwig (Wiley, 2020-05-27)
  • Hauser, Stephen L.; Bar-Or, Amit; Comi, Giancarlo; Correale, Jorge; Coyle, Patricia K.; Cross, Anne H.; de Seze, Jerome; Leppert, David; Montalban, Xavier; Selmaj, Krzysztof; Wiendl, Heinz; Kerloeguen, Cecile; Willi, Roman; Li, Bingbing; Kakarieka, Algirdas; Tomic, Davorka; Goodyear, Alexandra; Pingili, Ratnakar; ASCLEPIOS I and ASCLEPIOS II Trial Groups (Massachusetts Medical Society, 2020-08-06)
    Background: Ofatumumab, a subcutaneous anti-CD20 monoclonal antibody, selectively depletes B cells. Teriflunomide, an oral inhibitor of pyrimidine synthesis, reduces T-cell and B-cell activation. The relative effects of ...

Buscar en DSpace


Búsqueda avanzada

Listar

Mi cuenta